- Filed
- Feb 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Feb 3, 2025 | 74.34M sh |
| Long Term Debt | Q1 2025 · Jan 3, 2025 | $338.76M |
| Long Term Debt | Q1 2025 · Sep 27, 2024 | $448.28M |
| Short Term Debt | Q1 2025 · Jan 3, 2025 | $160.64M |
| Short Term Debt | Q1 2025 · Sep 27, 2024 | $0 |
| Short Term Investments | Q1 2025 · Jan 3, 2025 | $423.82M |
| Short Term Investments | Q1 2025 · Sep 27, 2024 | $435.08M |
| Cash And Equivalents | Q1 2025 · Jan 3, 2025 | $232.7M |
| Cash And Equivalents | Q1 2025 · Sep 27, 2024 | $146.81M |
| Current Liabilities | Q1 2025 · Jan 3, 2025 | $272.41M |
| Current Liabilities | Q1 2025 · Sep 27, 2024 | $108.18M |
| Total Liabilities | Q1 2025 · Jan 3, 2025 | $692.74M |
| Total Liabilities | Q1 2025 · Sep 27, 2024 | $629.3M |
| Current Assets | Q1 2025 · Jan 3, 2025 | $982.44M |
| Current Assets | Q1 2025 · Sep 27, 2024 | $903.08M |
| Total Assets | Q1 2025 · Jan 3, 2025 | $1.84B |
| Total Assets | Q1 2025 · Sep 27, 2024 | $1.76B |
| Shares Diluted | Q1 2025 · Dec 29, 2023 | 72.29M sh |
| Stock Repurchased | Q1 2025 · Dec 29, 2023 | $11.55M |
| Capex | Q1 2025 · Dec 29, 2023 | $4.65M |
| Operating Cash Flow | Q1 2025 · Dec 29, 2023 | $33.1M |
| Stockholders Equity | Q1 2025 · Dec 29, 2023 | $1.02B |
| Stockholders Equity | Q1 2025 · Sep 29, 2023 | $947.6M |
| Eps Diluted | Q1 2025 · Dec 29, 2023 | $0.17 |
| Eps Basic | Q1 2025 · Dec 29, 2023 | $0.18 |
| Sga Expense | Q1 2025 · Dec 29, 2023 | $36.89M |
| Rd Expense | Q1 2025 · Dec 29, 2023 | $39.41M |
| Net Income | Q1 2025 · Dec 29, 2023 | $12.53M |
| Operating Income | Q1 2025 · Dec 29, 2023 | $11.01M |
| Gross Profit | Q1 2025 · Dec 29, 2023 | $87.31M |
| Cost Of Revenue | Q1 2025 · Dec 29, 2023 | $69.84M |
| Revenue | Q1 2025 · Dec 29, 2023 | $157.15M |